A 3-month lifestyle modification program resulted in weight loss and improvement in eating habits, physical activity level, and A1c in patients at risk for type 2 diabetes.
Patients who underwent Roux-en-Y gastric bypass experienced greater weight loss and slightly higher diabetes remission rates than patients who underwent sleeve gastrectomy.
Incidence of type 1, type 2 diabetes increased; rates of increase higher in racial/ethnic minorities.
Menopause is linked to unfavorable health effects in women with type 2 diabetes, but older age at menarche may be associated with a decrease in these adverse effects.
Gout incidence rate significantly reduced with SGLT2 inhibitor vs GLP-1 receptor agonist.
Benefits seen for diabetes remission, weight loss, changes in metabolic parameters.
The American Diabetes Association (ADA) has published an update to their Standards of Medical Care in Diabetes for 2020.
Significant links persisted after adjustment for markers of nutritional quality, metabolic comorbidities.
The risk for type 1 and type 2 diabetes from childhood into adulthood is increased in preterm-born individuals.
eGFR did not significantly change with supplementation vs placebo in patients with type 2 diabetes.
Odds of diabetic kidney disease higher in obese teens receiving medical therapy vs bariatric surgery for T2DM.
For patients with type 2 diabetes, apparent treatment-resistant hypertension increases risk for cardiovascular events and mortality.
Patients with both T2DM, previous vertebral fracture have twofold risk for incident nonvertebral fracture.
In patients with type 2 diabetes mellitus, anemia is associated with the development of diabetic retinopathy.
A larger percentage of weight loss regained after an intensive lifestyle intervention was positively associated with certain cardiometabolic risk factors in type 2 diabetes.
Mortality risk for flu-related hospitalizations lower for those with vs without type 2 diabetes.
Reduction seen for risk of dialysis, transplantation, or death due to kidney disease.
Approximately 1 in 5 people with HIV also has prevalent DM, and control of hemoglobin A1c levels in these patients may have a beneficial effect on CD4 counts.
Among older individuals with type 2 diabetes, insulin use is least prevalent in those in good health, and discontinuation of insulin treatment is most likely in healthier patients.
Cardiorenal disease is commonly the first cardiovascular disease manifestation in patients with type 2 diabetes.